Real life outcomes vs. clinical trial results.
Two questions that clinicians should answer as they attempt to apply the results of clinical trials to clinical practice are: (1) will statistically significant results be reproduced in their clinical practice; and (2) if nothing goes wrong in a clinical trial, is everything alright? Regarding the f...
| Published in: | Journal of Ophthalmic & Vision Research Vol. 14; no. 1; pp. 88 - 93 |
|---|---|
| Main Author: | |
| Format: | pictorial tables/charts Journal Article |
| Published: |
Knowledge E DMCC
Jan-Mar2019
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=134601121&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 134601121 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 20082010 AY5S jtl: Journal of Ophthalmic & Vision Research issn: 20082010 maglogo: N pubinfo: dt: Jan-Mar2019 vid: 14 iid: 1 pid: 35682 pub: Knowledge E DMCC artinfo: ui: 134601121 134601121 134601121 10.4103/jovr.jovr_279_18 134601121 ppf: 88 ppct: 5 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Real life outcomes vs. clinical trial results. aug: au: Zarbin, Marco affil: Institute of Ophthalmology and Visual Science, Rutgers-New Jersey Medical School, Rutgers University, Newark, New Jersey sug: subj: Clinical Trials Physicians Psychosocial Factors Outcomes Research Research Subjects Medical Practice, Evidence-Based Decision Support Systems, Clinical ab: Two questions that clinicians should answer as they attempt to apply the results of clinical trials to clinical practice are: (1) will statistically significant results be reproduced in their clinical practice; and (2) if nothing goes wrong in a clinical trial, is everything alright? Regarding the first question, when considering the results of a randomized, multicenter, prospective, controlled clinical trial, two questions that cannot be addressed by simply by reading the trial results and that only the practicing clinician can answer are: (1) is the study population representative of the patient about to be treated; and (2) is the totality of evidence outside the trial (including the clinician's own extensive experience) consistent with the trial result? Regarding the second question, clinicians are advised to recognize that most studies, even Phase 3 trials, are underpowered to accurately assess the risk of low frequency events. pubtype: Academic Journal doctype: pictorial tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|